<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                International Journal Parasitology: Drugs Drug Resistance 2 (2012) 243&#226;&#8364;&#8220;248 <br />  <br />  <br />  <br />                                                              Contents lists available SciVerse ScienceDirect <br />  <br />                                                  International Journal Parasitology: <br />                                                        Drugs Drug Resistance <br />                                                     journal homepage: www.elsevier.com/locate/ijpddr <br />  <br />  <br />  <br /> Invited article <br />  <br /> The Entamoeba histolytica serum-inducible transmembrane kinase EhTMKB1-9 <br /> is involved intestinal amebiasis <br /> Mayuresh M. Abhyankar a,&#226;&#8225;&#8216;, Shiteshu Shrimal b,1, Carol A. Gilchrist a, Alok Bhattacharya b, <br /> William A. Petri Jr. a <br /> a <br />     Division Infectious Diseases International Health, School Medicine, University Virginia Health System, Charlottesville, VA 22908, USA <br /> b <br />     School Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India <br />  <br />  <br />  <br /> a r t c l e            n f o                           b s t r c t <br />  <br /> Article history:                                           Entamoeba histolytica possesses family approximately 100 putative transmembrane kinases (TMKs), <br /> Available online 30 January 2012                           indicating parasite extensive means environmental sensing. The TMKs been <br />                                                            divided sub-groups based sequence composition intracellular kinase well <br /> Keywords:                                                  extracellular cysteine-rich domains. EhTMKB1-9 recently shown expressed prolifer- <br /> Entamoeba                                                  ating trophozoites induced serum. Interference EhTMKB1-9 antisense RNA knockdown or <br /> Transmembrane kinase                                       expression truncated protein diminished proliferation, adhesion cytotoxicity. Here report the <br /> Amebic colitis <br />                                                            involvement EhTMKB1-9 phagocytosis virulence function formation amebic colitis. <br /> Amebic liver abscess <br />                                                            Trophozoites induced express higher levels wild type EhTMKB1-9 showed increased capacity for <br />                                                            endocytosis. In contrast, cells compromised EhTMKB1-9 expression antisense inhibition <br />                                                            showed signi&#239;&#172;?cantly lower levels phagocytosis endocytosis experimental conditions. <br />                                                            The role EhTMKB1-9 virulence factor studied using animal models amebiasis. Trophozoites <br />                                                            expressing high levels mutant protein lacking kinase domain showed competitive disadvantage <br />                                                            regard <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span>survival</span> invasive <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> murine model amebic colitis. The same <br />                                                            parasites however, compromised ability generate abscess gerbil model inva- <br />                                                            sive liver amebiasis. EhTMKB1-9 second member &#226;&#8364;&#732;&#226;&#8364;&#732;B&#226;&#8364;&#8482;&#226;&#8364;&#8482; group EhTMKs be <br />                                                            deployed parasite intestinal infection. TMKs attractive targets drug development <br />                                                            requirement virulence proliferation. <br />                                                                            &#195;&#8220; 2012 Australian Society Parasitology Published Elsevier Ltd. All rights reserved. <br />  <br />  <br />  <br />  <br /> 1. Introduction                                                                                 trophozoites. Humans natural host. E. histolytica infec- <br />                                                                                                 tion produce colitis characterized ulceration invasion of <br />     Entamoeba histolytica, causative agent amebiasis, pro-                          intestinal wall. In advanced cases, trophozoites spread dis- <br /> tozoan parasite responsible severe morbidity                                 tant organs including liver, lungs brain (Samuel L, 2003). Cytol- <br /> 100,000 deaths worldwide (Haque et al., 2003; Petri et al., 2009).                              ysis phagocytosis target cell major pathological <br /> After Plasmodium spp., E. histolytica estimated second                             feature disease factors contributing <span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span> <br /> major leading cause deaths protozoan parasite. It                                cytolysis important understand amebic invasion. <br /> therefore important understand virulence factors involved                                   Trophozoites demonstrated persist humans for <br /> in production invasive disease order identify novel drug                           months, suggest able evade im- <br /> targets treat parasitic infection.                                                      mune (Haque et al., 2002). E. histolytica transmembrane ki- <br />     The parasite exhibits biphasic life cycle consisting non-                              nases (EhTMKs) initially thought involved antigenic <br /> motile, transmissible cysts motile, replicating, invading                                   variation, showed similarity variant speci&#239;&#172;?c <br />                                                                                                 surface protein (VSP) Giardia lamblia (Beck et al., 2005). Recent <br />   &#226;&#8225;&#8216; Corresponding author. Address: Division Infectious Diseases Interna-                 studies favor role EhTMKs principal signaling <br /> tional Health, School Medicine, University Virginia Health System, 345 Crispell           molecules, especially parasite-host interface (Buss et al., <br /> Dr., Carter Harrison Building Room 1705A, Charlottesville, VA 22908, USA. Tel.: +1              2010). Similar metazoan counterparts, EhTMKs <br /> 434 924 5167; fax: +1 434 924 0075.                                                             characterized far (including PATMK, TMK39 EhTMKB1-9) <br />     E-mail addresses: mma3a@virginia.edu (M.M. Abhyankar), sshrimal@gmail.com                   cysteine-rich extracellular domains containing furin like or <br /> (S. Shrimal), cg2p@virginia.edu (C.A. Gilchrist), alok.bhattacharya@gmail.com (A. <br /> Bhattacharya), wap3g@virginia.edu (W.A. Petri Jr.). <br />                                                                                                 epidermal growth factor (EGF) -like moieties. These signature <br />   1 <br />      Present address: Department Biochemistry Molecular Pharmacology,                    extracellular domains metazoan TMKs thought in- <br /> UMass Medical School, Worcester, MA 01605, USA.                                                 volved aggregation TMKs. E. histolytica survives complex <br />  <br /> 2211-3207/$ - matter &#195;&#8220; 2012 Australian Society Parasitology Published Elsevier Ltd. All rights reserved. <br /> doi:10.1016/j.ijpddr.2012.01.002 <br />  244                          M.M. Abhyankar et al. / International Journal Parasitology: Drugs Drug Resistance 2 (2012) 243&#226;&#8364;&#8220;248 <br />  <br />  <br /> gut environment competing constantly bacteria nutrients                     overexpressing dominant negative mutant protein tested <br /> and space, need sense changes environment                       competence phagocytose kill cells cause <br /> order escape host defense mechanisms, trigger transition                      infection host target tissues- gut liver. The ability of <br /> to persistent environmentally resistant infective cyst life                  parasite survive invade gut assessed competition <br /> stage express proteins important virulence tissue                    experiment using mouse model amebiasis. Similarly, gerbil <br /> invasion. This demands repertoire highly specialized network-                   liver abscess model used study parasite&#226;&#8364;&#8482;s ability induce <br /> ing signaling pathways.                                                           liver abscess. As case PATMK, EhTMKB1-9 be <br />     Transmembrane kinases represent major classes                      important intestinal infections causing liver ab- <br /> cell surface receptors involved essential cellular pro-                   scesses. The studies con&#239;&#172;?rm role EhTMKB1-9 an <br /> cesses eukaryotic cells. These molecules typically                 important virulence factor open possibilities screening <br /> sense environmental cues transduce signals appropriate                    molecules potentially target similar <br /> intracellular pathways. Completion sequenced genomes hu-                       extracellular receptors. <br /> man-infective non-infective protozoa recent years <br /> has allowed kinome parasites de&#239;&#172;?ned (Naula <br />                                                                                      2. Materials methods <br /> et al., 2005). Bioinformatic analysis predicts 90 TMKs in <br /> E. histolytica, 9 Dictyostelium discoideum (Goldberg et al., <br />                                                                                      2.1. Strains cell culture <br /> 2006); 88 Monosiga brevicollis (Manning et al., 2008), 11 Plas- <br /> modium falciparum (Ward et al., 2004) 10 TMKs Trypano- <br />                                                                                          E. histolytica strain HM1:IMSS trophozoites grown under <br /> soma brucei (Parsons et al., 2005). An EhTMK typically contains <br />                                                                                      axenic conditions TYI-S-33 medium supplemented 15% <br /> four domains &#226;&#8364;&#8220; N-terminal signal peptide, extracellular domain <br />                                                                                      adult bovine serum, 1  Diamond&#226;&#8364;&#8482;s vitamins, penicillin (100 U/ <br /> rich CXXC repeats, single transmembrane helix intra- <br />                                                                                      ml) streptomycin (100 lg/ml) (Diamond et al., 1978). The <br /> cellular tyrosine-kinase like domain (Beck et al., 2005). E. histolyti- <br />                                                                                      cloning <span id='am-2' about='xsp:length' typeof='owl:Thing'>length</span> EhTMKB1-9 (TMK9-S), dominant negative <br /> ca TMKs subdivided sub-groups (A, B1&#226;&#8364;&#8220;3, C, D1&#226;&#8364;&#8220; <br />                                                                                      mutant (TMK9-Dn) antisense construct (TMK9-AS) tetra- <br /> 2, E F) based kinase domain sequence com- <br />                                                                                      cycline inducible expression vector pEhHYG-tetR-O-CAT (TOC) has <br /> position extracellular domains. <br />                                                                                      described previously (Shrimal et al., 2010). Please note that <br />     Many signaling pathways shown active E. his- <br />                                                                                      AS construct cloned using &#239;&#172;?rst 1 kb region of <br /> tolytica hypothesize allow pathogen appro- <br />                                                                                      EhTMKB1-9 ORF. The initial 307 nucleotides unique to <br /> priately respond various environmental stimuli. The &#239;&#172;?rst <br />                                                                                      EhTMKB1-9 rest 707 nucleotides share sequence similar- <br /> Entamoeba TMK functionally characterized TMK B1.I.1 was <br />                                                                                      ity member family viz. EhTMKB1-10. <br /> shown play active role E. histolytica cell proliferation (Mehra <br />                                                                                      However, expression EhTMKB1-10 1000-fold less <br /> et al., 2006). To date additional EhTMKs studied. <br />                                                                                      compared EhTMKB1-9 seen quantitative real time PCR <br /> PATMK (phagosome associate transmembrane kinase) a <br />                                                                                      measurements normal HM1 proliferating cells (Shrimal et al., <br /> member EhTMK B-family participated erythrophagocyto- <br />                                                                                      2010). The transfected lines carrying different constructs gen- <br /> sis identi&#239;&#172;?ed screening proteins involved in <br />                                                                                      erated using established protocols (Olvera et al., 1997; Asgharpour <br /> the identi&#239;&#172;?cation ingestion apoptotic corpses (Boettner et al., <br />                                                                                      et al., 2005). In short, amebae (2.2   105 ml 1) washed in <br /> 2008). Subsequently, proven single E. histolytica tro- <br />                                                                                      Medium 199 (Invitrogen, CA) supplemented 5.7 mM cysteine, <br /> phozoite express members sub-groups (A, B1, <br />                                                                                      1 mM ascorbic acid, 25 mM HEPES (pH 6.8) mixed 10 lg <br /> D1 E) utilize multiple TMKs non-redundant func- <br />                                                                                      DNA 30 ll Superfect (Qiagen). Treated amebae incu- <br /> tions (Buss et al., 2010). TMK-39 shown regulate internal- <br />                                                                                      bated 3 h 37 &#194;&#176;C, followed overnight recovery TYI-S-33 <br /> ization polyanionic macromolecules; TMK-54 was <br />                                                                                      medium 37 &#194;&#176;C. Where mentioned, cultures induced <br /> shown major growth factor receptor regulating the <br />                                                                                      using 20 lg/ml tetracycline 48 h TYI-33-S medium. <br /> expression heavy chain subunit Gal/GalNAc surface lectin <br /> (Buss et al., 2010). EhTMKB1-9 (TMK-95) recent member <br /> of TMK family functionally characterized (Shrimal                2.2. Murine model amebic colitis <br /> et al., 2010). EhTMKB1-9 serum responsive one <br /> of &#239;&#172;?rst examples inducible genes Entamoeba. The kinase do-                    The murine model amebic colitis utilized mice carrying two <br /> main ser/thr tyr kinase activities similar                copies R allele codon 223 leptin receptor, described <br /> to dual speci&#239;&#172;?city kinase splA D. discoidium. Adhesion                (Stratigopoulos et al., 2009; Duggal et al., 2011). All ani- <br /> the &#239;&#172;?rst steps pathogenesis prerequisite host cell killing.             mal protocols approved Institutional Animal Care and <br /> Cells containing reduced levels EhTMKB1-9 high levels dom-                  Use Committee. Mice maintained speci&#239;&#172;?c-pathogen&#226;&#8364;&#8220; <br /> inant negative mutant protein resulted decreased proliferation,                   free conditions University Virginia monitored closely <br /> target cell adherence cell killing. The results clearly                   general well-being. For competition experiments respective <br /> showed EhTMKB1-9 important signaling molecule                            transfectant lines mixed 1:1 ratio. For intracecal inoc- <br /> likely involved parasite proliferation vivo.                             ulations total 2   106 trophozoites log phase injected <br />     Protein phosphorylation regulates aspect cell life                   volume 150 ll laparotomy described (Houpt et al., <br /> protein kinases termed major drug targets                    2002). In mice inoculated induced amebae, induction <br /> of twenty-&#239;&#172;?rst century. Plasmodial kinases consid-                     maintained addition 0.2 mg/ml doxycycline 5% <br /> ered targets drug development and, based structural diver-                    sucrose drinking water. All mice sacri&#239;&#172;?ced 4 days after <br /> gence, selectivity mammalian kinases viewed                     infection. Amebae isolated vivo locations &#226;&#8364;&#8220; the <br /> a realistic possibility (Doerig, 2004). Protein kinases               luminal gut gut mucosal surface. DNA extracted sam- <br /> pursued drug targets trypanosomes Leishmania (Naula                        ples subjected construct speci&#239;&#172;?c quantitative PCR. <br /> et al., 2005). <br />     The objective present work validate vitro                   2.3. Gerbil model amebic liver abscess formation <br /> observations using animal models amebiasis assess <br /> EhTMKB1-9&#226;&#8364;&#8482;s pathogenesis properties view previous stud-                       Liver abscesses induced described (Chadee Meerov- <br /> ies showing potential important virulence factor. Parasites                itch, 1989). Transfectants carrying control plasmid <br />                               M.M. Abhyankar et al. / International Journal Parasitology: Drugs Drug Resistance 2 (2012) 243&#226;&#8364;&#8220;248                245 <br />  <br />  <br /> expressing dominant negative EhTMKB1-9 grown pres-                       ability pathogenic E. histolytica strains ingest erythro- <br /> ence absence 20 lg/ml tetracycline 48 h prior infection.                cytes compared nonpathogenic species Entamoeba dispar <br /> 1   106 similarly treated transfectant lines inoculated dif-               used historically diagnose Entamoeba infections <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> ferent liver lobes 50&#226;&#8364;&#8220;60 day old Mogolian male gerbil (Meriones                   stool specimen (Trissl et al., 1978). Both amebic Gal/GalNAc <br /> unguiculatus). One transfectant injected right anterior                 inhibitable lectin transmembrane kinases been <br /> lobe liver left lobe. This order reversed              shown important mediating attachment ameba to <br /> in half animals. After recovery surgery, induction                   erythrocytes (Petri et al., 1987; Boettner et al., 2008). EhTMKB1-9 <br /> maintained appropriate adding 2 mg/ml doxycycline                        previously shown constitute 95% total ex- <br /> the drinking water. Gerbils sacri&#239;&#172;?ced 7 days past infection, liv-               pressed B1 family TMKs important adhesion as <br /> ers extracted abscess weights measured.                                     destruction CHO cells (Shrimal et al., 2010). We measured the <br />                                                                                      ability trophozoites overexpressing de&#239;&#172;?cient EhTMKB1-9 <br /> 2.4. Quantitative PCR                                                                phagocytose red blood cells. Parasites grown absence pres- <br />                                                                                      ence tetracycline incubated red blood cells and <br />    Closed circular DNA isolated cecal contents mod-                    extracellular erythrocytes lysed distilled water. Parasites <br /> i&#239;&#172;?cation previously published methods (Pontes et al., 2002;                       containing ingested erythrocytes lysed concentrated <br /> Sikorski et al., 2002). Amebae collected washed                        formic acid heme present (as measured by <br /> phosphate-buffered saline (PBS), lysed addition                        OD) used surrogate marker quanti&#239;&#172;?cation of <br /> 700 ll Rapid One-Step Extraction buffer &#226;&#8364;&#8220; 10 mM Tris (pH 8.0),                       ingested erythrocytes. The cells containing vector alone, the <br /> 300 mM EDTA (pH 8.0), 1% sodium lauryl sulfate, 1% polyvinylpoly-                    sense construct over-expression, did signi&#239;&#172;?cant <br /> pyrrolidone. The lysate heated 95 &#194;&#176;C 10 min, vortexed                     change erythrophagocytosis. Over expression dominant <br /> and returned 95 &#194;&#176;C 10 min. The cell lysate centri-                   negative mutant (TMK9-Dn) antisense RNA showed signi&#239;&#172;?cant <br /> fuged 14,000 g 10 min room temperature. Five                       reduction phagocytosis (Fig. 1A). <br /> microliters supernatant collected, mixed 50 ll                       To determine role EhTMKB1-9 general endocytosis <br /> cold 3 M sodium acetate (pH 5.3, 4 &#194;&#176;C) 1 ml cold ethanol                      pathway, measured uptake 10-kDa &#239;&#172;&#8218;uid-phase marker <br /> ( 20 &#194;&#176;C), immediately centrifuged 14,000 g 15 min.                        RITC-dextran. The cells containing vector did any <br /> DNA pellet washed 500 ll 70% ethanol                                signi&#239;&#172;?cant change uptake presence absence tet- <br /> ( 20 &#194;&#176;C), dried vacuum, resuspended 50 mM MOPS                          racycline. Trophozoites induced express length <br /> buffer (50 mM MOPS (morpholinepropanesulfonic acid), 750 mM                          EhTMKB1-9 showed signi&#239;&#172;?cantly higher &#239;&#172;&#8218;uorescence indicating <br /> NaCl (pH 7.5) &#239;&#172;?nal volume 0.75 ml. The sample                       increased endocytosis activity (Fig. 1B), cells induced to <br /> then puri&#239;&#172;?ed using Zymo plasmid puri&#239;&#172;?cation kit (Zymo                            express antisense RNA showed reduced endocytosis. Sur- <br /> Inc.). The eluted DNA passed twice Zymo-Spin IV-HRC                       prisingly, cells induced express dominant negative mutant <br /> &#239;&#172;?ltration column, DNA subjected PCR construct                        protein showed change endocytic activity. The results <br /> speci&#239;&#172;?c primers. TOC plasmid detected using primers spe-                      suggested level endocytosis reduced anti- <br /> ci&#239;&#172;?c chloamphenicol acetyl transferase (CAT) gene. The                       sense inhibition EhTMKB1-9 gene expression. This indi- <br /> primers used &#226;&#8364;&#8220; forward 50 -TGGAGTGAATACCACGACGA-30                              cate greater role extracellular domain the <br /> and reverse 50 -GGGCGAAGAAGTTGTCCATA-30 . The TMK9-Dn                                kinase domain EhTMKB1-9 endocytosis. <br /> expression plasmid detected using following pair of <br /> primers: forward 50 -ATTGAAGGAGGATATGCATGTGA-30 re-                              3.2. Expression dominant negative EhTMKB1-9 mutant confers <br /> verse 50 -TGATGATGATGATGATGTGATCC-30 .                                               competitive disadvantage amebae host gut <br />  <br />                                                                                         To test EhTMKB1-9 acts virulence factor establishing <br /> 2.5. Erythrophagocytosis assay <br />                                                                                      invasive intestinal infection used murine model amebic <br />                                                                                      colitis (Guo et al., 2011). LepR Q223R mice infected intrace- <br />    The assay performed described (Mora-Galindo et al., <br />                                                                                      cally 1:1 mixture amebae induced express dominant <br /> 1997). Brie&#239;&#172;&#8218;y, trophozoites red blood cells mixed to- <br />                                                                                      negative EhTMKB1-9 vector backbone. As control, another <br /> gether ratio 1:100, pelleted washed times <br />                                                                                      set used 1:1 mixed uninduced amebae. Amebae were <br /> with distilled water burst open non-engulfed RBCs. The pellets <br />                                                                                      induced 48 h 20 lg/ml tetracycline indicated <br /> containing parasites ingested RBCs lysed concentrated <br />                                                                                      animal inoculations. Eight mice infected group. <br /> formic acid (90%), solutions read spectrophotometer <br />                                                                                      All mice sacri&#239;&#172;?ced 4 days post-inoculation trophozoites <br /> at 400 nm. <br />                                                                                      recovered different locations. Those isolated from <br />                                                                                      cecal contents considered luminal re- <br /> 2.6. RITC-dextran uptake assay                                                       moved luminal surface cecum scraping were <br />                                                                                      considered mucosal (Gilchrist et al., 2010). Closed circular DNA <br />    Endocytosis assay quantitate uptake RITC-dextran                        extracted described materials methods used <br /> performed described (Sahoo et al., 2004). Brie&#239;&#172;&#8218;y, trophozoites                    quantitative PCR analysis. Construct-speci&#239;&#172;?c primer pairs al- <br /> and RITC-dextran incubated 30 min 36 &#194;&#176;C pel-                    lowed compare surviving populations mutant con- <br /> leted washed times PBS. The cells lysed                     trol trophozoites quantitatively. The ratio cultured input <br /> by resuspending PBS containing triton-X100 &#239;&#172;&#8218;uorescence                        amebae induced uninduced sets used correct the <br /> was measured.                                                                        qPCR ratio dominant negative vector set mice. <br />                                                                                      The ratio TMK9-Dn TOC vector signi&#239;&#172;?cantly lower in <br /> 3. Results                                                                           case luminal amebae (p &lt; 0.01) mucosal amebae <br />                                                                                      (p &lt; 0.01) (Fig. 2). This indicated number TMK9-Dn <br /> 3.1. EhTMKB1-9 enhances erythrophagocytosis endocytosis                          expressing amebae decreased substantially gut loca- <br />                                                                                      tions. This consistent having competitive disad- <br />    Erythrophagocytosis common assays used assess                    vantage gut environment. In contrast ratio TMK9-Dn <br /> virulence potential laboratory strains Entamoeba. Difference                   TOC vector comparable parasites mixed <br />  246                               M.M. Abhyankar et al. / International Journal Parasitology: Drugs Drug Resistance 2 (2012) 243&#226;&#8364;&#8220;248 <br />  <br />  <br />  <br />  <br /> Fig. 1. Role EhTMKB1-9 phagocytosis pinocytosis. Expression transfectants uninduced (grey bars) induced (black bars) 20 lg/ml tetracycline for <br /> 48 h. (A) Quanti&#239;&#172;?cation erythrophagocytosis cells showing over-expression suppression EhTMKB1-9. Trophozoites incubated RBCs 10 min 37 &#194;&#176;C <br /> followed lysis adherent RBCs chilled water. The trophozoites phagocytosed RBCs lysed using formic acid heme released was <br /> quantitated measuring absorbance 400 nm. The values expressed average independent experiments &#194;&#177;SD. (B) Quanti&#239;&#172;?cation liquid phase pinocytosis. <br /> The different transfectants incubated 2 mg/ml RITC-dextran PBS 30 min subjected quantitative estimation spectro&#239;&#172;&#8218;uorometer. The values are <br /> expressed average independent experiments &#194;&#177;SD. Abbreviations: TOC &#226;&#8364;&#8220; tetracycline inducible vector control; TMK9 S &#226;&#8364;&#8220; construct expressing length <br /> EhTMKB1-9; TMK9 Dn &#226;&#8364;&#8220; construct expressing kinase domain deletion mutant EhTMKB1-9; TMK9 AS &#226;&#8364;&#8220; construct expressing antisense RNA N-terminal 1 kb region of <br /> EhTMKB1-9. &#226;?&#8222;p value &lt;0.05; &#226;?&#8222;&#226;?&#8222;p value &lt;0.001. <br />  <br />  <br />  <br />                                                                                           3.3. EhTMKB1-9 essential amebic liver abscess formation <br />  <br />                                                                                               We tested EhTMKB1-9 important for <br />                                                                                           intestinal amebiasis played role liver infection. We used the <br />                                                                                           gerbil model amebic liver abscess formation. Amebae carrying <br />                                                                                           TMK9-Dn TOC construct grown presence absence of <br />                                                                                           tetracycline 48 h prior inoculations. One million trophozoites <br />                                                                                           similarly treated groups used inoculate different <br />                                                                                           liver lobes animal. The order transfectants <br />                                                                                           inoculated reversed half animals avoid any <br />                                                                                           potential bias regarding site infection. Eight animals were <br />                                                                                           used group. Gerbils sacri&#239;&#172;?ced 4 days post-infection, <br />                                                                                           livers isolated abscess weights measured. Amebae from <br />                                                                                           abscesses cultured TYI-S-33 broth con&#239;&#172;?rm infections <br />                                                                                           (data shown). No signi&#239;&#172;?cant difference noticed between <br />                                                                                           uninduced induced control (Fig. 3A) TMK9-Dn express- <br />                                                                                           ing (Fig. 3B) amebae indicated similar abscess weights. We <br />                                                                                           concluded expression EhTMKB1-9 did appear essential <br />                                                                                           liver infection. <br />                                                                                               TMK9-Dn transfectants general caused smaller abscesses <br />                                                                                           irrespective induction state. The difference abscess <br />                                                                                           weights statistically signi&#239;&#172;?cant induced TOC <br />                                                                                           TMK9-Dn transfectants (p &lt; 0.005). This totally unex- <br />                                                                                           pected length TMKB1-9 shown important <br /> Fig. 2. Competitive disadvantage amebae expressing dominant negative <br />                                                                                           cell proliferation (Shrimal et al., 2010). Surprisingly, differ- <br /> TMKB1-9 protein murine model amebic colitis. Amebae induced for <br /> 48 h 20 lg/ml tetracycline indicated. Mice carrying susceptible            ence signi&#239;&#172;?cant uninduced transfectants <br /> Q223R Lepr allele infected intracecally induced TOC TMK9-Dn                 lines removing outlier TMKDn group using <br /> amebae mixed 1:1 ratio. As control, equal number mice infected          Grubb&#226;&#8364;&#8482;s test. This likely TMK9-Dn background <br /> with mixture uninduced ameba. Induction maintained addition          expression vector (Hamann et al., 1997) turn <br /> 0.2 mg/ml doxycycline 5% sucrose drinking water post-infectious challenge <br /> as appropriate. All mice sacri&#239;&#172;?ced 4 days infection, ratios the <br />                                                                                           interfering wild type TMK function. This further <br /> TMK9-Dn control TOC vector determined construct speci&#239;&#172;?c qPCR            emphasizes EhTMKB1-9&#226;&#8364;&#8482;s role proliferation vivo. <br /> amebae isolated different vivo locations &#226;&#8364;&#8220; luminal gut (luminal) or <br /> the gut surface (mucosal). Values corrected input data, statistical <br />                                                                                           4. Discussion <br /> signi&#239;&#172;?cance determined using t test. The difference ratio statistically <br /> signi&#239;&#172;?cant luminal mucosal samples (p &lt; 0.01). <br />                                                                                              EhTMKB1-9 virulence factor important amebic colitis. <br /> and maintained laboratory cultures used inoculating mice                           Expression mutant EhTMKB1-9 conferred disadvantage <br /> (data shown), suggesting decrease proliferation                           survival invasive properties amebae intestine. <br /> and invasion TMK9-Dn expression unique intesti-                           Competition experiment gave direct proof role of <br /> nal lumen.                                                                                EhTMKB1-9 invasive disease survival inside host <br />                                   M.M. Abhyankar et al. / International Journal Parasitology: Drugs Drug Resistance 2 (2012) 243&#226;&#8364;&#8220;248                         247 <br />  <br />  <br />  <br />  <br /> Fig. 3. Induction EhTMKB1-9 dominant negative mutant did affect liver abscess formation: Amebae transfected control vector plasmid expressing <br /> kinase domain deletion mutant EhTMKB1-9 grown presence absence 20 lg/ml tetracycline 48 h prior infection. Amebae (106) inoculated into <br /> different liver lobes 50&#226;&#8364;&#8220;60 day old Mongolian male gerbils. Induction maintained appropriate adding 2 mg/ml doxycycline drinking water. Gerbils <br /> were sacri&#239;&#172;?ced 7 days infection, livers extracted abscess weights measured. (A) Comparison abscess weights formed uninduced induced vector <br /> transfectants (B) comparison abscess weights formed uninduced induced EhTMKB9-Dn transfectants. The X-axis shows transfectant line treatment <br /> whereas Y-axis represents abscess weight. <br />  <br />  <br /> gut. In contrast, EhTMKB1-9 did role liver                       (ErbB) family proteins present mammalian cells. Each ErbB <br /> infection. Expression EhTMK9-Dn mutant did sig-                          member does active kinase domain, activate <br /> ni&#239;&#172;?cant effect degree abscess formation seen                         relevant pathway ligand induced hetero-dimerization <br /> comparison abscess weights induced EhTMK9-Dn ver-                             partner active kinase domain (Linggi Carpen- <br /> sus control transfectants. E. histolytica employ different                      ter, 2006). This explain negative effect endocytosis <br /> virulence factors different environments.                                             downregulation length molecule. <br />     Formation colitis liver abscess appear require                            Expression TMK9-Dn showed impairment multiple viru- <br /> distinct virulence factors. Silencing amoebapore A impaired par-                      lence functions including proliferation, adhesion, phagocytosis <br /> asite&#226;&#8364;&#8482;s ability cause liver abscess did affect ability                 target cell destruction (Shrimal et al., 2010 study). It <br /> cause tissue destruction colonic xenograft model amebiasis                       important parasites maintain virulence <br /> (Zhang et al., 2004). Over expression cysteine protease-2 re-                         functions order divide gut environment, cells <br /> duced vitro monolayer destruction effect liver ab-                      constantly washed away replaced. The inability of <br /> scess formation (Hellberg et al., 2001). In previous work                         TMK9-Dn cells survive gut suggested competi- <br /> had discovered phagosome associated TMK (PATMK)                                 tion experiment indicates key role EhTMKB1-9 intestinal <br /> was important establishment gut liver infec-                      infection. It possible parasite relies major virulence <br /> tions. We conclude virulence program required                                factor tissue speci&#239;&#172;?c infection backup factors over- <br /> E. histolytica successful intestinal infection differs                   lapping functions interference help host <br /> required liver infection.                                                            develop better immune response clearance infec- <br />     It proposed rapid phagocytosis host cells                     tion. Although EhTMKB1-9 PATMK important for <br /> give E. histolytica advantage persistence human gut                         intestinal infection, in&#239;&#172;&#8218;uences phagocytosis differ signi&#239;&#172;?- <br /> clearing dead cells preventing release host immunomodula-                         cantly. It possible TMKs belonging group <br /> tory signals turn elicit in&#239;&#172;?ltration in&#239;&#172;&#8218;ammatory                       (but different subgroups) retained ability carry <br /> cells (Boettner et al., 2008). PATMK participated erythrophago-                       redundant functions extent ensure estab- <br /> cytosis (Boettner et al., 2008). Downregulation shRNAs                           lishment parasite natural host. <br /> expression C terminal deletion mutant PATMK, de-                                  It interesting quantitate expression different <br /> creased erythrophagocytosis P50%. Expression PATMK mu-                             members group involved intestinal infection <br /> tant reduced infection rate 30% mouse model                            vivo. This developing antibodies conserved <br /> colitis. Consistent this, EhTMKB1-9 play role                      regions closely related members group TMK <br /> in phagocytosis endocytosis. In present studies, effect                      proteins serve attractive target drug design. <br /> of regulating EhTMKB1-9 dramatic compared                             It remains discovered ligands stimulate EhTMKB1-9 <br /> to downregulation PATMK. Phagocytosis endocytosis as-                         mechanism EhTMKs transduce signals <br /> says showed 630% decrease. It likely EhTMKB1-9                         intracellularly. It important EhTMKB1-9 <br /> be primary receptor red blood cells partic-                       modulates amebic surface lectins adherence decreased. <br /> ipating process non-receptor accessory molecule. Previ-                          Given essential role EhTMKs play onset infection, <br /> ous studies support observation speci&#239;&#172;?c enrichment                        idea targeting EhTMKs therapeutic strategy promis- <br /> seen EhTMKB1-9 phagocytic cups erythrophagocyto-                           ing one. Protein kinases second important <br /> sis (Somlata et al., 2011). One observations                      group drug targets G-protein-coupled receptors, to <br /> course study antisense RNA EhTMKB1-                         important roles parasite proliferation establishment <br /> 9 affected endocytosis expression kinase deletion mutant                          invasive disease (Cohen, 2002). It proposed protein <br /> did not. It possible EhTMKB1-9 lacking kinase domain                         kinases, 60% sequence identity human <br /> could function similar epidermal growth factor receptor                           counterparts, speci&#239;&#172;?cally inhibited (Vieth et al., 2004; <br />  248                                   M.M. Abhyankar et al. / International Journal Parasitology: Drugs Drug Resistance 2 (2012) 243&#226;&#8364;&#8220;248 <br />  <br />  <br /> Naula et al., 2005). Most protozoan protein kinases                             Haque, R., Duggal, P., Ali, I.M., Hossain, M.B., Mondal, D., Sack, R.B., Farr, B.M., Beaty, <br />                                                                                                      T.H., Petri Jr., W.A., 2002. Innate acquired resistance amebiasis in <br /> putative homologues higher eukaryotes rarely P60% <br />                                                                                                      Bangladeshi children. J. Infect. Dis. 186, 547&#226;&#8364;&#8220;552. <br /> homology (Doerig et al., 2002) ideal can-                               Haque, R., Huston, C.D., Hughes, M., Houpt, E., Petri Jr., W.A., 2003. Amebiasis. N. <br /> didates drug design. This concept validated trypanoso-                                   Engl. J. Med. 348, 1565&#226;&#8364;&#8220;1573. <br /> matids, target Leishmania CDK3 54% identity                                  Hellberg, A., Nickel, R., Lotter, H., Tannich, E., Bruchhaus, I., 2001. Overexpression of <br />                                                                                                      cysteine proteinase 2 Entamoeba histolytica Entamoeba dispar increases <br /> to human counterpart inhibited ef&#239;&#172;?ciently speci&#239;&#172;?cally                                     amoeba-induced monolayer destruction vitro does augment amoebic <br /> the designed inhibitor (Grant et al., 2004). In work                                     liver abscess formation gerbils. Cell Microbiol. 3, 13&#226;&#8364;&#8220;20. <br /> identi&#239;&#172;?ed EhTMKs belonging family in-                                   Houpt, E.R., Glembocki, D.J., Obrig, T.G., Moskaluk, C.A., Lockhart, L.A., Wright, R.L., <br />                                                                                                      Seaner, R.M., Keepers, T.R., Wilkins, T.D., Petri Jr., W.A., 2002. The mouse model <br /> volved non-redundant functions including cell phagocytosis                                        amebic colitis reveals mouse strain susceptibility infection and <br /> and colitis. Development inhibitor molecules target closely                                  exacerbation disease CD4+ T cells. J. Immunol. 169, 4496&#226;&#8364;&#8220;4503. <br /> related EhTMKs family advantageous. Future                                     Linggi, B., Carpenter, G., 2006. ErbB receptors: new insights mechanisms and <br />                                                                                                      biology. Trends Cell Biol. 16, 649&#226;&#8364;&#8220;656. <br /> experiments directed role multiple TMKs                                   Manning, G., Young, S.L., Miller, W.T., Zhai, Y., 2008. The protist, Monosiga brevicollis, <br /> simultaneously intestinal virulence program E. histolytica.                                tyrosine kinase signaling network elaborate diverse found <br />                                                                                                      known metazoan. Proc. Natl. Acad. Sci. USA 105, 9674&#226;&#8364;&#8220;9679. <br />                                                                                                  Mehra, A., Fredrick, J., Petri Jr., W.A., Bhattacharya, S., Bhattacharya, A., 2006. <br /> Acknowledgement                                                                                      Expression function family transmembrane kinases the <br />                                                                                                      protozoan parasite Entamoeba histolytica. Infect. Immun. 74, 5341&#226;&#8364;&#8220;5351. <br />                                                                                                  Mora-Galindo, J., Guti&#195;&#169;rrez-Lozano, M., Anaya-Vel&#195;&#161;zquez, F., 1997. Entamoeba <br />   This work supported NIH grant 5 R01 AI026649-20                                          histolytica: kinetics hemolytic activity, erythrophagocytosis digestion <br /> W.A. Petri.                                                                                          erythrocytes. Arch. Med. Res. 28 (Spec no.), 200&#226;&#8364;&#8220;201. <br />                                                                                                  Naula, C., Parsons, M., Mottram, J.C., 2005. Protein kinases drug targets in <br />                                                                                                      trypanosomes Leishmania. Biochim. Biophys. Acta 1754, 151&#226;&#8364;&#8220;159. <br /> References                                                                                       Olvera, A., Olvera, F., Vines, R.R., Recillas-Targa, F., Lizardi, P.M., Dhar, S., <br />                                                                                                      Bhattacharya, S., Petri, W., Jr., Alag&#195;&#179;n, A., 1997. Stable transfection of <br /> Asgharpour, A., Gilchrist, C., Baba, D., Hamano, S., Houpt, E., 2005. Resistance                  Entamoeba histolytica trophozoites lipofection. Arch. Med. Res. 28 (Spec <br />     intestinal Entamoeba histolytica infection conferred innate immunity                   no.), 49&#226;&#8364;&#8220;51. <br />     Gr-1+ cells. Infect. Immun. 73, 4522&#226;&#8364;&#8220;4529.                                                   Parsons, M., Worthey, E.A., Ward, P.N., Mottram, J.C., 2005. Comparative analysis of <br /> Beck, D.L., Boettner, D.R., Dragulev, B., Ready, K., Nozaki, T., Petri Jr., W.A., 2005.              kinomes pathogenic trypanosomatids: Leishmania major, <br />     Identi&#239;&#172;?cation gene expression analysis large family transmembrane                    Trypanosoma brucei Trypanosoma cruzi. BMC Genomics 6, 127. <br />     kinases related Gal/GalNAc lectin Entamoeba histolytica. Eukaryotic Cell           Petri Jr., W.A., Smith, R.D., Schlesinger, P.H., Murphy, C.F., Ravdin, J.I., 1987. Isolation <br />     4, 722&#226;&#8364;&#8220;732.                                                                                      galactose-binding lectin mediates vitro adherence of <br /> Boettner, D.R., Huston, C.D., Linford, A.S., Buss, S.N., Houpt, E., Sherman, N.E., Petri             Entamoeba histolytica. J. Clin. Invest. 80, 1238&#226;&#8364;&#8220;1244. <br />     Jr., W.A., 2008. Entamoeba histolytica phagocytosis human erythrocytes                    Petri, W.A., Haque, R., Mondal, D., Karim, A., Molla, I.H., Rahim, A., Faruque, A.S.G., <br />     involves PATMK, member transmembrane kinase family. PLoS Pathog.                        Ahmad, N., Kirkpatrick, B.D., Houpt, E., Snider, C., 2009. Prospective case-control <br />     4, e8.                                                                                           study association common enteric protozoal parasites and <br /> Buss, S.N., Hamano, S., Vidrich, A., Evans, C., Zhang, Y., Crasta, O.R., Sobral, B.W.,               diarrhea Bangladesh. Clin. Infect. Dis. 48, 1191&#226;&#8364;&#8220;1197. <br />     Gilchrist, C.A., Petri Jr., W.A., 2010. Members Entamoeba histolytica                 Pontes, L.A., Dias-Neto, E., Rabello, A., 2002. Detection polymerase chain reaction <br />     transmembrane kinase family play non-redundant roles growth                               Schistosoma mansoni DNA human serum feces. Am. J. Trop. Med. Hyg. <br />     phagocytosis. Int. J. Parasitol. 40, 833&#226;&#8364;&#8220;843.                                                    66, 157&#226;&#8364;&#8220;162. <br /> Chadee, K., Meerovitch, E., 1989. Entamoeba histolytica: diffuse liver in&#239;&#172;&#8218;ammation            Sahoo, N., Labruy&#195;&#168;re, E., Bhattacharya, S., Sen, P., Guill&#195;&#169;n, N., Bhattacharya, A., 2004. <br />     gerbils (Meriones unguiculatus) experimentally induced amebic liver                         Calcium binding protein 1 protozoan parasite Entamoeba histolytica <br />     abscess. J. Protozool. 36, 154&#226;&#8364;&#8220;158.                                                              interacts actin involved cytoskeleton dynamics. J. Cell. Sci. 117, <br /> Cohen, P., 2002. Protein kinases &#226;&#8364;&#8220; major drug targets twenty-&#239;&#172;?rst                         3625&#226;&#8364;&#8220;3634. <br />     century? Nat. Rev. Drug Discov. 1, 309&#226;&#8364;&#8220;315.                                                  Samuel L, S.J., 2003. Amoebiasis. Lancet 361, 1025&#226;&#8364;&#8220;1034. <br /> Diamond, L.S., Harlow, D.R., Cunnick, C.C., 1978. A new medium axenic                    Shrimal, S., Bhattacharya, S., Bhattacharya, A., 2010. Serum-dependent selective <br />     cultivation Entamoeba histolytica Entamoeba. Trans. R. Soc. Trop.                   expression EhTMKB1-9, member Entamoeba histolytica B1 family of <br />     Med. Hyg. 72, 431&#226;&#8364;&#8220;432.                                                                           transmembrane kinases. PLoS Pathog. 6, e1000929. <br /> Doerig, C., Meijer, L., Mottram, J.C., 2002. Protein kinases drug targets parasitic        Sikorski, J., M&#195;&#182;hle, M., Wackernagel, W., 2002. Identi&#239;&#172;?cation complex <br />     protozoa. Trends Parasitol. 18, 366&#226;&#8364;&#8220;371.                                                         composition, strong strain diversity directional selection local <br /> Doerig, C., 2004. Protein kinases targets anti-parasitic chemotherapy.                        Pseudomonas stutzeri populations marine sediment soils. Environ. <br />     Biochim. Biophys. Acta 1697, 155&#226;&#8364;&#8220;168.                                                            Microbiol. 4, 465&#226;&#8364;&#8220;476. <br /> Duggal, P., Guo, X., Haque, R., Peterson, K.M., Ricklefs, S., Mondal, D., Alam, F., Noor,        Somlata, Bhattacharya, S., Bhattacharya, A., 2011. A C2 domain protein kinase <br />     Z., Verkerke, H.P., Marie, C., Leduc, C.A., Chua Jr., S.C., Myers Jr., M.G., Leibel, R.L.,       initiates phagocytosis protozoan parasite Entamoeba histolytica. Nat. <br />     Houpt, E., Gilchrist, C.A., Sher, A., Porcella, S.F., Petri Jr., W.A., 2011. A <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-236' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span>mutation</span>          Commun. 2, 230. <br />     leptin receptor associated Entamoeba histolytica infection                 Stratigopoulos, G., LeDuc, C.A., Matsuoka, N., Gutman, R., Rausch, R., Robertson, S.A., <br />     children. J. Clin. Invest. 121, 1191&#226;&#8364;&#8220;1198.                                                       Myers Jr., M.G., Chung, W.K., Chua Jr., S.C., Leibel, R.L., 2009. Functional <br /> Gilchrist, C.A., Moore, E.S., Zhang, Y., Bousquet, C.B., Lannigan, J.A., Mann, B.J., Petri,          consequences human leptin receptor (LEPR) Q223R transversion. Obesity <br />     W.A., 2010. Regulation virulence Entamoeba histolytica URE3-BP                      (Silver Spring) 17, 126&#226;&#8364;&#8220;135. <br />     transcription factor. MBio 1.                                                                Trissl, D., Mart&#195;&#173;nez-Palomo, A., la Torre, M., la Hoz, R., P&#195;&#169;rez Su&#195;&#161;rez, E., <br /> Goldberg, J.M., Manning, G., Liu, A., Fey, P., Pilcher, K.E., Xu, Y., Smith, J.L., 2006. The         1978. Surface properties Entamoeba: increased rates human erythrocyte <br />     dictyostelium kinome-analysis protein kinases simple model                         phagocytosis pathogenic strains. J. Exp. Med. 148, 1137&#226;&#8364;&#8220;1143. <br />     organism. PLoS Genet. 2, e38.                                                                Vieth, M., Higgs, R.E., Robertson, D.H., Shapiro, M., Gragg, E.A., Hemmerle, H., 2004. <br /> Grant, K.M., Dunion, M.H., Yardley, V., Skaltsounis, A.-L., Marko, D., Eisenbrand, G.,               Kinomics-structural biology chemogenomics kinase inhibitors and <br />     Croft, S.L., Meijer, L., Mottram, J.C., 2004. Inhibitors Leishmania mexicana                  targets. Biochim. Biophys. Acta 1697, 243&#226;&#8364;&#8220;257. <br />     CRK3 cyclin-dependent kinase: chemical library screen antileishmanial                    Ward, P., Equinet, L., Packer, J., Doerig, C., 2004. Protein kinases human <br />     activ <br /> </body></html>